Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 39 (8), 651-662
- https://doi.org/10.1080/08916930601061686
Abstract
Systems medicine is an emerging concept that acknowledges the complexity of a multitude of non-linear interactions among molecular and physiological variables. Under this new paradigm, rather than a collection of symptoms, diseases are seen as the product of deviations from a robust steady state compatible with life. This concept requires the incorporation of mathematics and physics to the more classical arsenal of physiology and molecular biology with which physicians are trained today. This review explores the diverse types of information that can be accumulated towards the understanding of multiple sclerosis (MS), a complex autoimmune disease that targets the central nervous system (CNS). The challenge of data integration and modeling of dynamical systems is discussed in the context of disease susceptibility and response to treatment. A theoretical framework that supports the use of combination therapy is also presented.Keywords
This publication has 101 references indexed in Scilit:
- Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout miceJournal of Comparative Neurology, 2006
- The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative?PLoS Medicine, 2006
- Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activityAnnals of Neurology, 2004
- Protection from autoimmune brain inflammation in mice lacking IFN‐regulatory factor‐1 is associated with Th2‐type cytokinesInternational Immunology, 2003
- A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesionsNature Genetics, 2002
- T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ IsoformThe Journal of Experimental Medicine, 2002
- Induction of experimental autoimmune encephalomyelitis in C57BL / 6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptorEuropean Journal of Immunology, 2000
- Experimental Autoimmune Encephalomyelitis in Intercellular Adhesion Molecule-1-Deficient MiceCellular Immunology, 1998
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- A Markov Model of the Natural History of Multiple SclerosisNeuroepidemiology, 1985